4//SEC Filing
SACHS BRUCE I 4
Accession 0000875320-25-000218
CIK 0000875320other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:19 PM ET
Size
6.5 KB
Accession
0000875320-25-000218
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Purchase
Common Stock
2025-08-06$389.36/sh+1,634$636,214→ 41,634 total - Purchase
Common Stock
2025-08-06$389.84/sh+3,366$1,312,201→ 45,000 total
Footnotes (3)
- [F1]Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60).
- [F2]Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
- [F3]Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001197036
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:19 PM ET
- Size
- 6.5 KB